Methylation profiling

Dataset Information

0

Early Epigenetic Downregulation of Tumor Suppressor WNK2 during Pancreatic Ductal Adenocarcinoma Development


ABSTRACT: BACKGROUND & AIMS: Pancreatic ductal adenocarcinoma (PDAC) is usually incurable. Contrary to genetic mechanisms involved in PDAC pathogenesis, epigenetic alterations are ill defined. Here we determine the contribution of epigenetically silenced genes to the development of PDAC. METHODS: We investigated methylated DNAs from PDACs, chronic pancreatitis and normal pancreatic tissues using Methyl-CpG immunoprecipitation followed by microarray hybridization. Promoter methylation of selected genes was confirmed with the Epityper assay. Expression levels were evaluated by quantitative RT-PCR. WNK2 was further investigated in tissue microarrays, methylation analysis of early pancreatic intraepithelial neoplasia (PanINs), mouse models for PDAC and pancreatitis, re-expression studies after demethylation, and cell growth assays using WNK2 overexpression. RESULTS: A total of 3.8% of 27.800 interrogated CpG islands were hypermethylated in PDAC versus normal and chronic pancreatitis tissues. Hypermethylation was confirmed in 12 out of 13 selected islands and was associated with gene silencing in 4 of them. The most prominently hypermethylated gene, WNK2, was further investigated. Demethylation assays confirmed the link between methylation and expression. WNK2 hypermethylation was higher in pancreatic tumor cells than in surrounding inflamed tissues and was observed in PanIN lesions as well as in a PDAC mouse model. WNK2 mRNA and protein expression were lower in PDAC and chronic pancreatitis compared to normal tissues both in patients and mouse models. Overexpression of WNK2 led to a reduced cell growth and WNK2 expression in tissues correlated negatively with the expression of pERK1/2, a downstream target of WNK2 responsible for cell proliferation. CONCLUSIONS: WNK2 is downregulated by promoter hypermethylation early in PDAC pathogenesis and may support tumor cell growth via the ERK-MAPK pathway.

ORGANISM(S): Homo sapiens

PROVIDER: GSE37480 | GEO | 2012/11/01

SECONDARY ACCESSION(S): PRJNA161013

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2012-11-01 | E-GEOD-37480 | biostudies-arrayexpress
2011-09-28 | E-GEOD-25820 | biostudies-arrayexpress
2022-07-25 | GSE208536 | GEO
2024-04-23 | PXD043111 | Pride
2011-09-28 | GSE25820 | GEO
2018-05-11 | GSE101462 | GEO
2020-10-29 | E-MTAB-9678 | biostudies-arrayexpress
| MSV000090255 | MassIVE
2020-07-14 | GSE123377 | GEO
2020-07-14 | GSE123375 | GEO